Search results for " protocol"

showing 10 items of 1320 documents

Automatic cell nuclei counting: a protocol to acquire images and to compare results between color and multispectral images

2013

International audience; High-throughput screening in histology and analysis need a necessary automatic cell or nucleus counting. Current methods and systems based on grayscale or color images give results with counting errors. We suggest to use multispectral imaging (with more than three bands) rather than color one for nucleus counting. A traditional acquisition chains uses a source of white light and a CCD camera in addition to the optical microscope. To pass to a multispectral acquisition, we use a Programmable Light Source (PLS) in the place of the white light source. This PLS is capable of generating different wavelengths in the visible spectrum. So, one color image and four multispect…

Automatic cell nuclei detection[ INFO.INFO-TS ] Computer Science [cs]/Signal and Image Processing[INFO.INFO-TS]Computer Science [cs]/Signal and Image Processing[INFO.INFO-TS] Computer Science [cs]/Signal and Image Processingacquisition protocolmultispectral imagingimage calibration[ SPI.SIGNAL ] Engineering Sciences [physics]/Signal and Image processingcolor imaging[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing[SPI.SIGNAL] Engineering Sciences [physics]/Signal and Image processing
researchProduct

A Comprehensive Survey on Cooperative Relaying and Jamming Strategies for Physical Layer Security

2019

Physical layer security (PLS) has been extensively explored as an alternative to conventional cryptographic schemes for securing wireless links. Many studies have shown that the cooperation between the legitimate nodes of a network can significantly enhance their secret communications performance, relative to the noncooperative case. Motivated by the importance of this class of PLS systems, this paper provides a comprehensive survey of the recent works on cooperative relaying and jamming techniques for securing wireless transmissions against eavesdropping nodes, which attempt to intercept the transmissions. First, it provides a in-depth overview of various secure relaying strategies and sch…

BeamformingComputer scienceJammingCryptography5G-tekniikka02 engineering and technologylangaton tiedonsiirto0203 mechanical engineering0202 electrical engineering electronic engineering information engineeringWirelessElectrical and Electronic Engineeringtietoturvabusiness.industryComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSPhysical layer020206 networking & telecommunications020302 automobile design & engineeringEavesdropping5G communicationsphysical layer security (PLS)jamming techniquesrelaying protocolsKey (cryptography)business5Glangattomat verkotComputer network
researchProduct

Decoding Children's Social Behavior

2013

We introduce a new problem domain for activity recognition: the analysis of children's social and communicative behaviors based on video and audio data. We specifically target interactions between children aged 1-2 years and an adult. Such interactions arise naturally in the diagnosis and treatment of developmental disorders such as autism. We introduce a new publicly-available dataset containing over 160 sessions of a 3-5 minute child-adult interaction. In each session, the adult examiner followed a semi-structured play interaction protocol which was designed to elicit a broad range of social behaviors. We identify the key technical challenges in analyzing these behaviors, and describe met…

Behavior Psychology Dataset Video analysis Speech Analysis AutismInter-action protocolsSocial and communicative behaviorInteraction protocol02 engineering and technologycomputer.software_genreAnnan data- och informationsvetenskapSession (web analytics)Activity recognitionTechnical challenges0202 electrical engineering electronic engineering information engineeringmedicineSocial behaviorAudio signal processingMultimediabusiness.industryDevelopmental disorders020207 software engineeringmedicine.diseaseSemi-structuredResearch questionsActivity recognitionProblem domainKey (cryptography)Autism020201 artificial intelligence & image processingArtificial intelligencePsychologybusinessOther Computer and Information SciencecomputerCognitive psychologySocial behavior2013 IEEE Conference on Computer Vision and Pattern Recognition
researchProduct

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.

2018

Splenectomy in addition to immunotherapy with rituximab can provide quick and sometimes durable disease control in patients with splenic marginal zone lymphoma (SMZL). However, systemic chemotherapy is ultimately required in many cases. The BRISMA (Bendamustine-rituximab as first-line treatment of splenic marginal zone lymphoma)/IELSG (International Extranodal Lymphoma Study Group)36 trial is an open-label, single arm phase II study designed by the IELSG in cooperation with the Fondazione Italiana Linfomi and the lymphoma Study Association according to Simon's two-stage method. The primary endpoint was complete response rate. Fifty-six patients with SMZL diagnosis confirmed on central revis…

BendamustineAdultMalemedicine.medical_specialtyPhases of clinical researchNeutropeniaGastroenterologyDisease-Free SurvivalDrug Administration ScheduleSettore MED/15 - Malattie Del Sangue03 medical and health sciences0302 clinical medicineInternal medicinefirst-line therapyAntineoplastic Combined Chemotherapy ProtocolsMedicineBendamustine HydrochlorideHumansSplenic marginal zone lymphomabendamustineAgedbusiness.industrySplenic NeoplasmsHematologyLymphoma B-Cell Marginal ZoneMiddle Agedmedicine.diseaseLymphomaimmunochemotherapyRegimenTreatment Outcome030220 oncology & carcinogenesisbendamustine; first-line therapy; immunochemotherapy; rituximab; Splenic Marginal Zone Lymphoma; HematologySplenectomyRituximabFemaleSplenic Marginal Zone LymphomaNeoplasm Recurrence LocalbusinessRituximabFebrile neutropenia030215 immunologymedicine.drugBritish journal of haematology
researchProduct

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

2021

The antibody-drug conjugate polatuzumab vedotin (pola) has recently been approved in combination with bendamustine and rituximab (pola-BR) for patients with refractory or relapsed (r/r) large B-cell lymphoma (LBCL). To investigate the efficacy of pola-BR in a real-world setting, we retrospectively analyzed 105 patients with LBCL who were treated in 26 German centers under the national compassionate use program. Fifty-four patients received pola as a salvage treatment and 51 patients were treated with pola with the intention to bridge to chimeric antigen receptor (CAR) T-cell therapy (n = 41) or allogeneic hematopoietic cell transplantation (n = 10). Notably, patients in the salvage and brid…

BendamustineOncologymedicine.medical_specialtyCancer ResearchImmunoconjugatesMedizinSalvage therapyInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansProgression-free survivalRetrospective StudiesSalvage TherapyLymphoid Neoplasiabusiness.industryAntibodies MonoclonalHematologyChemotherapy regimenPolatuzumab vedotinTransplantationRegimenbacteriaRituximabbusinessmedicine.drug
researchProduct

Knowledge, attitudes, and practices about homelessness and willingness-to-pay for housing-first across 8 European countries: a survey protocol

2018

Contains fulltext : 200223.pdf (Publisher’s version ) (Open Access) Background: Most European countries report rising numbers of people experiencing homelessness. For those with mental disorders, interventions are centered on achieving mental health and drug rehabilitation alongside housing readiness, often to the detriment of access to housing. Notwithstanding, more European countries are investing in a new model, Housing First (HF), which postulates immediate access to permanent housing with no initial requirements for treatment. While results of the European HF programs are published on individual-level data, little is known about the opinions of the general population about homelessness…

Bidding game; Contingent valuation; Europe; Homelessness; HousingFirst; Knowledge attitudes practices (KAP); Public opinion; Willingness-to-pay (WTP); Public Health Environmental and Occupational HealthHousing FirstPopulationPsychological interventionPractices (KAP)Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]practices (KAP)Study Protocol03 medical and health sciences0302 clinical medicineWillingness to payPolitical scienceKnowledge attitudes practices (KAP)Contingent valuation030212 general & internal medicine10. No inequalityeducationSocioeconomicsPublic opinionHealth policyValuation (finance)Contingent valuationeducation.field_of_studyattitudes030505 public healthWillingness-to-pay (WTP)HousingFirstlcsh:Public aspects of medicineHousing firstEnvironmental and Occupational Health1. No povertyPublic Health Environmental and Occupational Healthlcsh:RA1-1270HomelessnessHousing First3. Good healthEuropeKnowledgeAttitudesRespondentBidding gameHousing FirstPublic Health0305 other medical science
researchProduct

Osteonecrosis in Hodgkin lymphoma treated by BEACOPP

2018

BleomycinAntineoplastic Combined Chemotherapy ProtocolTreatment OutcomeDoxorubicinVincristineProcarbazineOsteonecrosiInternal MedicinePrednisoneCyclophosphamideHodgkin DiseaseEtoposideHuman
researchProduct

Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H…

2020

Abstract Objectives Given a lack of universally-accepted standard-of-care treatment for patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC), study objectives were to assess treatment utilization and survival outcomes for R/M HNSCC in the real-world setting. Materials and methods A multi-site retrospective chart review was conducted in Europe (Germany, United Kingdom, Italy, Spain), Asia Pacific (Australia, South Korea, Taiwan), and Latin/North America (Brazil and Canada) to identify patients who initiated first-line systemic therapy for R/M HNSCC between January 2011 and December 2013. Patients were followed through December 2015 to collect clinical characte…

Bridged-Ring CompoundsMaleCanadaCancer Researchmedicine.medical_specialtymedicine.medical_treatmentTaiwanMedizinCetuximabPlatinum CompoundsKaplan-Meier EstimateSystemic therapy03 medical and health sciences0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsRepublic of KoreaConfidence IntervalsmedicineHumans030223 otorhinolaryngologySurvival analysisAgedRetrospective StudiesChemotherapyCetuximabSquamous Cell Carcinoma of Head and Neckbusiness.industryHead and neck cancerAustraliaMiddle Agedmedicine.diseaseHead and neck squamous-cell carcinomaConfidence intervalEuropeRegimenMethotrexateTreatment OutcomeOncologyHead and Neck Neoplasms030220 oncology & carcinogenesisFemaleTaxoidsFluorouracilNeoplasm Recurrence LocalOral SurgerybusinessBrazilmedicine.drugOral Oncology
researchProduct

Relationship Between Thymidylate Synthase and p53 and Response to FEC Versus Taxane Adjuvant Chemotherapy for Breast Carcinoma

2011

Many drugs can be used for adjuvant therapy of breast cancer, including anthracyclines, cyclophosphamide, 5-fluorouracil (5-fU) and, recently, taxanes (TXT) have shown promising results. 5-FU blocks thymidylate synthase (TS) which cross-links p53 mRNA, inhibiting its synthesis. TS overexpression is one of the main mechanisms involved in 5-FU drug resistance. Enough p53 mutations can confer resistance to chemotherapy using anthracyclines and 5-FU, while are associated with improved responses to TXT. The aim of this study was to examine the TS and p53 levels in tumor samples and to compare the efficacy of FEC (5-FU, epirubicin, cyclophosphamide) and TXT chemotherapy in a group of patients wit…

Bridged-Ring CompoundsOncologymedicine.medical_specialtyCyclophosphamidemedicine.medical_treatmentBreast NeoplasmsThymidylate synthaseBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumormedicineAdjuvant therapyHumansPharmacology (medical)CyclophosphamideEpirubicinNeoplasm StagingPharmacologyChemotherapyTaxanebiologybusiness.industryThymidylate SynthasePrognosismedicine.diseaseImmunohistochemistryInfectious DiseasesOncologyChemotherapy AdjuvantFluorouracilbiology.proteinCancer researchFemaleTaxoidsFluorouracilTumor Suppressor Protein p53businessmedicine.drugEpirubicinJournal of Chemotherapy
researchProduct

THE BIAS (BULLYING IN SICILIAN SCHOOL) PILOT STUDY: INVESTIGATING THE PREVALENCE OF BULLYING IN SCHOOL OF PALERMO CITY. A RESEARCH STUDY PROTOCOL

2017

Being a serious threat to physical and emotional health of children and adolescents all over the world, bullying in school represents an important public health issue. Since 2007, in Italy, the Ministry of Education (MIUR) has promoted activities to face and prevent bullying in schools of all levels while at the same time national and local Health Authorities have implemented effective social-health strategies. To date, the lack of consistent data needed to properly describe the concerning increase of this Public Health phenomenon prevents both the ability to systematically survey and measure the effectiveness of the public health strategies against bullying. The Bullying In Sicilian School…

Bullying prevention public health child and adolescent health study protocolSettore MED/42 - Igiene Generale E Applicata
researchProduct